Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - OPERATING INCOME
Operating Income ENTA - Enanta Pharmaceuticals, Inc.
-122 M
LAST VALUE
0.87%
2 YEAR CAGR
-33.95%
5 YEAR CAGR
-22.17%
10 YEAR CAGR